From fingersticks to a glance at your phone — how Dexcom’s G7 turns the daily guesswork of Type 2 diabetes into real-time confidence for millions of Americans.

For decades, living with Type 2 diabetes meant living in the dark. A finger prick gave you a single number a few times a day, a snapshot, never the full picture. Which meant leaving most people to guess how a meal, a workout, or a stressful afternoon was really affecting their body. For the tens of millions of Americans with Type 2 who aren’t on insulin, that guesswork has been the norm, even as the disease quietly drives $412.9 billion in annual U.S. healthcare costs.

Dexcom, a global leader in continuous glucose monitoring for twenty-five years, set out to end the guessing. The Dexcom G7 15 Day, the longest-lasting wearable and most accurate CGM ever cleared by the FDA, shows glucose in real time on a phone, with no fingersticks, so people can finally see how food, activity, and medication move their numbers as it happens.

This segment makes that real through one of Dexcom’s “Warriors.” who was diagnosed with Type 2 and decided it would not define them. With the G7 on the back of their arm, they learned how their own body responded to the food they loved and the hours they moving, and used that knowledge to make smarter choices and bring their A1C down. In the studio, Dr. Thomas Grace joins Dr. Drew on the couch to translate the science into plain English: why real-time data changes behavior, why accuracy matters, and why CGM remains dramatically underused — especially among people with Type 2 not on insulin and seniors on Medicare, many of whom don’t realize how affordable it can be.]

For anyone living with Type 2 diabetes, caring for someone who is, or simply trying to take control of their health, this is the segment that shows what it looks like to stop guessing and start seeing.